Cdk5 Inhibitor Shows Early Potential in Easing Anxiety, Aiding Neurons
Researchers have developed a new suppressor of cyclin-dependent kinase 5 (Cdk5) — an enzyme whose activity is associated with neuropsychiatric and neurodegenerative conditions — that can robustly enter the brain and appears to be more potent than previous, similar molecules. When injected into the bloodstream, the new molecule, named 25-106,…